AMY TEH Portfolio
Invests via Arrowpoint Investment Partners (Singapore) Pte. Ltd. | Managed by AMY TEH
Invests via Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Managed by AMY TEH
Automatically Tracked
AMY TEH Profile
Growth-stage investor and operator focused on scaling technology companies, with hands-on experience across product, strategy and operations. AMY TEH has led venture and private-equity investments in SaaS, fintech and marketplaces, sits on multiple boards and advises founders on go-to-market and unit economics. Known for active portfolio management, deal sourcing in Southeast Asia and structuring follow-on capital.
Growth-stage investor and operator focused on scaling technology companies, with hands-on experience across product, strategy and operations. AMY TEH has led venture and private-equity investments in SaaS, fintech and marketplaces, sits on multiple boards and advises founders on go-to-market and unit economics. Known for active portfolio management, deal sourcing in Southeast Asia and structuring follow-on capital.
Investment Philosophy & Strategy
Growth-stage, hands-on investor focused on scaling technology businesses across SaaS, fintech and marketplaces in Southeast Asia. Prioritises unit-economics-driven go-to-market plays, structured follow-on capital and active board engagement to accelerate product-market fit and durable revenue expansion. Investment style blends operational value-add with disciplined capital allocation, a multi-year growth horizon, selective risk-taking around market-leading founders, and emphasis on repeatable monetisation and scalable distribution channels.
Growth-stage, hands-on investor focused on scaling technology businesses across SaaS, fintech and marketplaces in Southeast Asia. Prioritises unit-economics-driven go-to-market plays, structured follow-on capital and active board engagement to accelerate product-market fit and durable revenue expansion. Investment style blends operational value-add with disciplined capital allocation, a multi-year growth horizon, selective risk-taking around market-leading founders, and emphasis on repeatable monetisation and scalable distribution channels.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
3.72%
Gain
Monthly
0.2%
Yearly
2.4%
Drawdown
24.61%
$80.72M
Equity
Holdings
$80.72M
Investment
$67.82M
$28.5M
Profit -$1.33M
Realized
$15.6M
Unrealized
$12.9M
Dividends
$3.83M
Goals
Avg. 100% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0%
Profit
-$1.33M
Win %
73%
This Week
Compared To Last Week
Gain
-2.51%
Profit
-$2.08M
Win %
73%
This Month
Compared to last month
Gain
-3.24%
Profit
-$2.7M
Win %
73%
This Year
Compared to last year
Gain
17.39%
Profit
$11.95M
Win %
76%
DXCM DexCom, Inc.
+6.2%
+$16,362.28 
BIIB Biogen Inc.
+6.12%
+$56,801.42 
OSG Octave Specialty Group, Inc.
+3.61%
+$29,225.28 
COO The Cooper Companies, Inc.
+3.16%
+$13,148.08 
GILD Gilead Sciences Inc.
+3.15%
+$49,590.43 
AMGN Amgen Inc.
+2.94%
+$51,979.69 
XLP Consumer Staples Select Sector SPDR Fund
+2.65%
+$13,923 
AXGN Axogen Inc.
+2.11%
+$13,312.94 
KWEB KraneShares CSI China Internet ETF
+1.91%
+$205.8 
REGN Regeneron Pharmaceuticals, Inc.
+1.83%
+$30,474.36 
BDN Brandywine Realty Trust
+1.75%
+$588.5 
TEVA Teva Pharmaceutical Industries Ltd. ADR
+1.63%
+$13,289.58 
BMRN Biomarin Pharmaceutical Inc.
+1.26%
+$36,295.65 
NVST Envista Holdings Corporation
+1.25%
+$3,015.34 
JNJ Johnson & Johnson
+1.2%
+$23,508.45 
UNH UnitedHealth Group Incorporated
+1.18%
+$25,845.28 
VRTX Vertex Pharmaceuticals Incorporated
+1.18%
+$19,275.75 
XLE Energy Select Sector SPDR Fund
+1.12%
+$5,397.5 
PFE Pfizer Inc.
+1.07%
+$18,983.52 
IOVA Iovance Biotherapeutics, Inc.
+0.84%
+$784.47 
LLY Eli Lilly and Company
+0.81%
+$4,119.44 
ILMN Illumina, Inc.
+0.69%
+$3,933.8 
BLTE Belite Bio, Inc.
+0.35%
+$3,122.08 
XLU Utilities Select Sector SPDR Fund
+0.33%
+$2,460 
595017BG8
0%
$0 
CLYM Climb Biotherapeutics, Inc.
-12.83%
-$43,770.2 
UAMY United States Antimony Corporation
-11.99%
-$8,112.46 
ERAS Erasca, Inc.
-10.42%
-$55,036.11 
TNGX Tango Therapeutics Inc.
-9.59%
-$59,342.7 
SMMT Summit Therapeutics Inc.
-8.88%
-$16,234.33 
LITE Lumentum Holdings Inc.
-7.11%
-$30,067 
MRNA Moderna, Inc.
-6.92%
-$80,783.32 
SYRE Spyre Therapeutics, Inc.
-6.76%
-$42,396.7 
GPCR Structure Therapeutics Inc.
-6.36%
-$13,219.45 
ALMS Alumis Inc.
-6.18%
-$21,415.18 
DYN Dyne Therapeutics Inc.
-6.15%
-$25,389.17 
IBRX ImmunityBio, Inc.
-4.72%
-$14,966.83 
CGON CG Oncology, Inc.
-4.58%
-$11,255.8 
GOOGL Alphabet Inc
-4.51%
-$520,754.71 
GOOG Alphabet Inc
-4.5%
-$4,998 
COGT Cogent Biosciences, Inc.
-4.5%
-$24,365.98 
PRAX Praxis Precision Medicines Inc.
-4.47%
-$54,933.75 
BIOA BioAge Labs, Inc.
-3.87%
-$18,285.92 
RVMD Revolution Medicines Inc.
-3.74%
-$54,920.19 
ORKA Oruka Therapeutics, Inc.
-3.73%
-$16,624.81 
PLUG Plug Power Inc.
-3.57%
-$884.31 
GDX VanEck Gold Miners ETF
-3.41%
-$5,050 
TWST Twist Bioscience Corporation
-3.24%
-$40,428 
CYTK Cytokinetics, Incorporated
-3.04%
-$18,543.88 
NTRA NATERA INC (Common Stock) – ticker 45E
-3.03%
-$24,948 
NKTR Nektar Therapeutics Inc.
-3.01%
-$5,815.65 
ASX ASE Technology Holding Co., Ltd. Sponsored ADR
-3%
-$219,004.64 
TYRA Tyra Biosciences, Inc.
-2.99%
-$7,820.64 
INSM Insmed Inc.
-2.89%
-$22,256.89 
ASND Ascendis Pharma A/S
-2.83%
-$90,011.2 
MDGL Madrigal Pharmaceuticals, Inc.
-2.82%
-$18,481.96 
FLTW Franklin FTSE Taiwan ETF
-2.76%
-$10,119.5 
EWT iShares MSCI Taiwan ETF
-2.49%
-$31,875 
XLK State Street Technology Select Sector SPDR ETF
-2.44%
-$888 
BBIO BridgeBio Pharma, Inc.
-2.43%
-$11,598.92 
PTGX Protagonist Therapeutics Inc.
-2.34%
-$29,566.38 
VSTM Verastem Inc.
-1.92%
-$3,978.7 
NMRA Neumora Therapeutics, Inc.
-1.53%
-$400 
AXSM Axsome Therapeutics, Inc.
-1.16%
-$45,266.76 
IONS Ionis Pharmaceuticals, Inc.
-0.94%
-$19,985.25 
EQH Equitable Holdings, Inc.
-0.93%
-$3,125.24 
PTCT PTC Therapeutics, Inc.
-0.74%
-$23,213.17 
SPY SPDR S&P 500 ETF Trust
-0.67%
-$2,137.8 
GMAB Genmab A/S Sponsored ADR
-0.65%
-$3,045.7 
UTHR United Therapeutics Corporation
-0.62%
-$1,741.73 
BNTX BioNTech SE
-0.62%
-$3,927.3 
XLI Industrial Select Sector SPDR Fund
-0.35%
-$2,112 
APGE Apogee Therapeutics Inc.
-0.22%
-$1,202.1 
TLT iShares 20+ Year Treasury Bond ETF
-0.15%
-$886.79 
INDA ISHARES MSCI INDIA ETF
-0.1%
-$25 
NBIX Neurocrine Biosciences Inc.
-0.06%
-$2,155.6 
XLF Financial Select Sector SPDR Fund
-0.03%
-$93 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 804 | Longs Won 167/804 20% | Profit Factor 2.54 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $524,449.38 |
| Average Win $281,465.54 | Best Trade (Mar 31) $11.47M | Sharpe Ratio -3.81 |
| Average Loss -$29,057.05 | Worst Trade (Mar 31) -$4.2M | Z-Score -5.16 (100%) |
| Commissions $0 | Avg. Trade Length 3m 3w 3d | Expectancy $35,442.04 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.06% | 0.98% | 11.25% |
| Consecutive Losing Trades | 2,778 | 2,500 | 2,222 | 1,944 | 1,667 | 1,389 | 1,111 | 833 | 556 | 278 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
